As TOP1-targetd therapies are extensively used for a variety of cancers and second-generation TOP1 inhibitors are being developed4, insights from our study may be relevant to other cancers treated with TOP1 inhibitors such as ovarian and small cell lung cancers. Here, TOP1 is linked to small cell lung carcinoma.